More than 400 of the pharmaceutical industry's most senior global executives have signed a joint statement condemning the decision of a federal judge in the US state of Texas to overturn the FDA's approval of mifepristone. …
Industry leaders unite in response to US court's ruling that overturns FDA approval
April 12, 2023 Latest NewsBioPharmaNews of the Day
Latest Video
New Stories
-
The unseen price of survival for women facing early breast cancer in Australia
March 27, 2026 - - Latest News -
This is the not so quiet demand and doctrine of rationed health care
March 27, 2026 - - Latest News -
If these can be presented as positives, then we really have become accustomed to terrible
March 26, 2026 - - Latest News -
Liberty expands into Asia Pacific life sciences insurance with new tailored offering
March 25, 2026 - - Australian Biotech -
Budget delivers progress, but hundreds of thousands still waiting for access
March 25, 2026 - - Latest News -
To what extent does the system even see itself as bound by external review?
March 25, 2026 - - Latest News -
PBAC agenda reflects increasing number of companies seeking revised recommendations
March 25, 2026 - - Latest News